This HTML5 document contains 139 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
n8	http://dx.doi.org/10.1093/JJCO/
schema	http://schema.org/
skos	http://www.w3.org/2004/02/skos/core#
rdfs	http://www.w3.org/2000/01/rdf-schema#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n12	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q50025731

rdf:type

wikibase:Item

schema:description

научна статия artículo científico publicado en 2017 wetenschappelijk artikel наукова стаття, опублікована в липні 2017 мақолаи илмӣ 2017年学术文章 מאמר מדעי 2017年学术文章 مقالة علمية نشرت في يوليو 2017 vědecký článek articol științific სამეცნიერო სტატია 2017 nî lūn-bûn artikulong pang-agham bilimsel makale artículu científicu επιστημονικό άρθρο 2017년 논문 জুলাই ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ научни чланак wissenschaftlicher Artikel 2017年學術文章 scientific article published in July 2017 article scientific บทความทางวิทยาศาสตร์ vitskapeleg artikkel tudományos cikk scientific article published in July 2017 article científic artigo científico scienca artikolo 2017年學術文章 artikull shkencor artykuł naukowy artikel ilmiah научная статья article scientifique vetenskaplig artikel научни чланак 2017年学术文章 vedecký článok vitenskapelig artikkel scientific article published in July 2017 2017年学术文章 articolo scientifico 2017年学术文章 2017年學術文章 artigo científico 2017年學術文章 artigo científico 2017年學術文章 2017年の論文 videnskabelig artikel udgivet juli 2017 tieteellinen artikkeli bài báo khoa học 2017年学术文章 naučni članak teaduslik artikkel

p:P577

wds:Q50025731-4F78E223-40CE-4440-BC61-40A398D1F467

wdt:P577

2017-07-01T00:00:00Z

p:P2860

wds:Q50025731-8F2866B5-91EA-4DDF-ABE3-56F38D220F97 wds:Q50025731-9885EAA0-CFD6-40DE-8F95-33A864EBD3BC wds:Q50025731-A6ECD006-BAED-451D-800B-11623E9E4B10 wds:Q50025731-B63F852D-6130-4ABE-8282-44EB3F8D55C2 wds:Q50025731-BD3ACA36-93EE-4777-BFC6-AE9257581D62 wds:Q50025731-CD65877C-F76C-454B-B75E-D1B69E33BCEE wds:Q50025731-D7BDA33B-CA67-476A-A5C9-1659434F8321 wds:Q50025731-EA5ABF4D-D20D-4020-91E3-964E78D4A780 wds:Q50025731-07777668-80C7-400A-8F69-0FF20C027BC3 wds:Q50025731-2748EF0C-2E38-48AD-A2F7-88D5D07A7F34 wds:Q50025731-4EBBA6F4-FB67-42C1-8F78-E5478826679B wds:Q50025731-ECF30DD3-EC92-4D3D-9265-7B2756389273

wdt:P2860

wd:Q70264109 wd:Q39311439 wd:Q87371992 wd:Q24201908 wd:Q34371245 wd:Q42525218 wd:Q34594112 wd:Q38404655 wd:Q46748533 wd:Q47969082 wd:Q56780258 wd:Q37920837

p:P2093

wds:Q50025731-341C0B5C-15C8-4DE9-911D-CF594A9587E2 wds:Q50025731-488F1E84-2378-4934-986C-95070706AC09 wds:Q50025731-1C499B10-A2CA-4E7C-8F3C-D3EE09FBD2F0 wds:Q50025731-172EFCCE-1452-4D6F-9DA8-4983B21C8783 wds:Q50025731-89A1E14D-3D2F-459D-B28E-C8E9A6BB2CD3 wds:Q50025731-5D737B54-C0C1-4C26-841F-4166D7339672 wds:Q50025731-AFFB652A-3E6D-4E09-9B9D-CEF34939AE64 wds:Q50025731-930CA429-940F-460D-B332-88ECFA13B16C wds:Q50025731-91C9E9A8-FD68-4C05-9170-A0538D0930F2 wds:Q50025731-D66705C0-FA83-402C-A16C-A6895E1C8A7B wds:Q50025731-C865B82C-A11D-470B-94B4-D7BCEB01EA4B wds:Q50025731-F1EECBED-0D1F-4F31-8BD3-E308863E54A6

wdt:P2093

Kenjiro Namikawa Dai Ogata Arata Tsutsumida Masutaka Furue Naoya Yamazaki Hiroshi Uchi Yoshio Kiyohara Shusuke Yoshikawa Tetsuya Tsuchida Taro Shibata Tatsuya Takenouchi Tomonori Mizutani

rdfs:label

Randomized phase III trial of adjuvant therapy with locoregional interferon beta versus surgery alone in stage II/III cutaneous melanoma: Japan Clinical Oncology Group Study (JCOG1309, J-FERON). Randomized phase III trial of adjuvant therapy with locoregional interferon beta versus surgery alone in stage II/III cutaneous melanoma: Japan Clinical Oncology Group Study (JCOG1309, J-FERON).

skos:prefLabel

Randomized phase III trial of adjuvant therapy with locoregional interferon beta versus surgery alone in stage II/III cutaneous melanoma: Japan Clinical Oncology Group Study (JCOG1309, J-FERON). Randomized phase III trial of adjuvant therapy with locoregional interferon beta versus surgery alone in stage II/III cutaneous melanoma: Japan Clinical Oncology Group Study (JCOG1309, J-FERON).

schema:name

Randomized phase III trial of adjuvant therapy with locoregional interferon beta versus surgery alone in stage II/III cutaneous melanoma: Japan Clinical Oncology Group Study (JCOG1309, J-FERON). Randomized phase III trial of adjuvant therapy with locoregional interferon beta versus surgery alone in stage II/III cutaneous melanoma: Japan Clinical Oncology Group Study (JCOG1309, J-FERON).

p:P1476

wds:Q50025731-A8559EC4-F015-4346-A669-614A9949E523

wdt:P1476

Randomized phase III trial of adjuvant therapy with locoregional interferon beta versus surgery alone in stage II/III cutaneous melanoma: Japan Clinical Oncology Group Study (JCOG1309, J-FERON).

p:P304

wds:Q50025731-67BD37B9-9742-4AF1-853E-C4DECC7A020A

wdt:P304

664-667

p:P31

wds:Q50025731-E8C2C7D0-5244-44EB-B67A-873E2624549D

wdt:P31

wd:Q13442814

p:P921

wds:Q50025731-58A4B19C-5A1A-4BEA-BCC0-236C4A36FF1C wds:Q50025731-5CB0ABAA-321E-4AFB-BF09-D78BBC3C7D6D

wdt:P921

wd:Q12322152 wd:Q42824827

p:P698

wds:Q50025731-EF1124FB-B933-4C2F-A167-97249A20796E

wdtn:P698

n12:29136453

wdt:P698

29136453

p:P1433

wds:Q50025731-8A1EA75E-CA2D-4F9B-9DEF-1C8B0BB6345B

wdt:P1433

wd:Q2231629

p:P433

wds:Q50025731-EB475F51-A9E9-4CDD-9EF0-7C894E968357

p:P478

wds:Q50025731-696DA59A-470A-4E4B-BD67-ECBABB175EE9

wdt:P433

7

wdt:P478

47

p:P356

wds:Q50025731-7304A5F9-AD5F-41B5-BA40-2500EC67BD37

wdtn:P356

n8:HYX063

wdt:P356

10.1093/JJCO/HYX063

p:P932

wds:Q50025731-A9FE1019-5E5C-4D41-BB0A-2A0CE7B8C379

wdt:P932

5896686